Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

Nature Medicine

Volumn 9, Issue 11, 2003, Pages 1370-1376

  Aicher, Alexandra ^a   Heeschen, Christopher ^a   Mildner Rihm, Christiane ^a   Urbich, Carmen ^a   Ihling, Christian ^b   Technau Ihling, Katja ^b   Zeiher, Andreas M ^a   Dimmeler, Stefanie ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW SUPPRESSION; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; MORTALITY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGENERATION; STEM CELL; WILD TYPE;

ANIMALS; ENZYME PRECURSORS; GELATINASES; ISCHEMIA; METALLOENDOPEPTIDASES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; STEM CELLS;

ANIMALIA;

EID: 0345276632     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm948     Document Type: Article

References (40)

1. Isner, J.M. & Losordo, D.W. Therapeutic angiogenesis for heart failure. Nat. Med. 5, 491-492 (1999).
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31 (1995).
3. Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997).
4. Takahashi, T. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438 (1999).
5. Shi, Q. et al. Evidence for circulating bone marrow-derived endothelial cells Blood 92, 362-367 (1998).
6. Risau, W. Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
7. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis, Nat. Med, 6, 389-395 (2000).
8. Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201 (2001).
9. Shintani, S. et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103, 897-903 (2001).
10. Moore, M.A. et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann. NY Acad. Sci, 938, 36-45 (2001).
11. Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637 (2002).
12. Asahara, T. et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18, 3964-3972 (1999).
13. Morrison, S.J., Shah, N.M. & Anderson, D.J. Regulatory mechanisms in stem cell biology. Cell 88. 287-298 (1997).
14. Kiger, A.A., White-Cooper, H. & Fuller, M.T. Somatic support cells restrict germline stem cell self-renewal and promote differentiation. Nature 407, 750-754 (2000).
15. Lapidot, T. & Petit, I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30, 973-981 (2002).
16. Murohara, T. et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101, 2567-2578 (1998).
17. Taylor, D.A., Hruban, R., Rodriguez, E.R. & Goldschmidt-Clermont, P.J. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? Circulation 106, 2-4 (2002).
18. Prosper, F., Stroncek, D., McCarthy, J.B. & Verfaillie, C.M. Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of α4β1 integrin expression and function J. Clin. Invest. 101, 2456-2467 (1998).
19. Vermeulen, M. et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 92, 894-900 (1998).
20. Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-848 (1999).
21. Hattori, K. et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849 (2002).
22. Gu, Z. et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death Science 297, 1186-1190 (2002).
23. De Palma, M., Venneri, M.A., Roca, C. & Naidini, L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9, 789-795 (2003).
24. Ziche, M. et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94, 2036-2044 (1994).
25. Murohara, T. et al. Role of endothelial nitric oxide synthase in endothelial cell migration Arterioscler. Thromb. Vasc. Biol. 19, 1156-1161 (1999).
26. Dimmeler, S., Haendeler, J., Nehls, M. & Zeiher, A.M. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J. Exp. Med. 185, 601-608 (1997).
27. + human bone marrow cells, Blood 87, 977-982 (1996).
28. Dimmeler, S. et al. Activation of nitric oxide synthase in endothelial cells via Akt-dependent phosphorylation. Nature 399, 601-605 (1999).
29. Fulton, D. et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601 (1999).
30. Eriksson, U. & Alitalo, K. VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies. Nat. Med. 8, 775-777 (2002).
31. Schachinger, V., Britten, M.B. & Zeiher, A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease, Circulation 101, 1899-1906 (2000).
32. Zeiher, A.M. Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon? Lancet 348, S10-S12 (1996).
33. Vasa, M. et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, E1-E7 (2001).
34. Tepper, O.M. et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786 (2002).
35. Hill, J.M. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600 (2003).
36. Fiering, S.N. et al Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry 12, 291-301 (1991).
37. Heeschen, C. et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 7, 833-839 (2001).
38. Mezey, E. et al. Transplanted bone marrow generates new neurons in human brains. Proc. Natl. Acad. Sci. USA 100, 1364-1369 (2003).
39. Dimmeler, S. et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108, 391-397 (2001).
40. Rajagopalan, S., Meng, X.P., Ramasamy, S., Harrison, D.G. & Galis, Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98, 2572-2579 (1996).